Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
JAK Inhibitors
•
Gastroenterology
•
Dermatology
•
Nephrology
Have you utilized JAK inhibitors in patients on dialysis?
Related Questions
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is your approach to using topical JAK inhibitors in the management of cutaneous manifestations of rheumatic disease?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
Do you prefer celecoxib over a nonselective NSAID in patients with chronic kidney disease?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
Would you start anticoagulation in a previously heathy patient with a new diagnosis of ANCA vasculitis (+PR3, RPGN, crescents on kidney biopsy) who presented with pancreatitis, splenic and renal infarcts and was also found to have CMV viremia?
What treatments have you found most effective for cholestatic pruritus?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
How do you approach treatment of SAPHO syndrome?
